Conclusions
Sulfonylureas have a variety of effects on pancreatic B-cells. In the present review an attempt has been made to identify those that appear fundamental from a mechanistic point of view and in that sense common to all hypoglycemic drugs tested. On several points the available able experimental information is limited. With this reservation in mind, the following general hypothesis is presented for the insulin-releasing action of this class of drugs. Hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids bind to the B-cell plasma membrane, a step in which hydrophobic anchoring is essential. Dissociated acidic COOH or SO2NHCO groups in the drugs are thus presented to an ion-gating protein in the plasma membrane, possibly in the vicinity of a pair of sulfur atoms. The reduced state of these sulfurs is promoted, preventing the formation of a disulfide bridge. K+ permeability is thereby decreased, favoring depolarization of the B-cell and Ca2+ influx through voltage-dependent channels. Finally, Ca2+ triggers the physiological apparatus for discharge of the insulin secretory granules. The effect of this insulinreleasing signal chain is amplified by cyclic AMP which increases in the B-cell as a consequence of depolarization and Ca2+ influx. This hypothesis does not attribute an ionophoretic role to the sulfonylureas per sebecause various experiments with cells and artificial membrane systems render such an idea apparently less tenable.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abrahamsson, H., and Berggren, P.-O., Efflux of radioactive Ca2+ from microcarrier-attached cloned rat insulinoma cells. Diabetologia25 (1983) 135.
Anianeyulu, R. Anjaneyulu, K., Couturier, E., and Malaisse, W.J., Opposite effects of hypoglycemic and hyperglycemic sulfonamides upon ionophore-mediated calcium transport. Biochem. Pharmac.29 (1980) 1879–1882.
Ashcroft, S.J.H., Hedeskov, C.J., and Randle, P.J., Glucose metabolism in mouse pancreatic islets. Biochem. J.118 (1970) 143–154.
Ashcroft, S.J.H., Weerasinghe, L.C.C., Bassett, J.M., and Randle, P.J., The pentose cycle and insulin release in mouse pancreatic islets. Biochem. J.126 (1972) 525–532.
Ashcroft, S.J.H., Weerasinghe, L.C.C., and Randle, P.J., Interrelationships of islet metabolism, ATP content and insulin release. Biochem. J.132 (1973) 223–231.
Borg, H., and Andersson, A., Long-term effects of glibenclamide on the insulin production, oxidative metabolism and quantitative ultrastructure of mouse pancreatic islets maintained in tissue culture at different glucose concentrations. Acta diabetol. lat.18 (1981) 65–83.
Boschero, A.C., Kawazu, S., Duncan, G., and Malaisse, W.J., Effect of glucose on K+ handling by pancreatic islets. FEBS Lett.83 (1977) 151–154.
Boschero, A.C., and Malaisse, W.J., Stimulus-secretion coupling of glucose-induced insulin release. XXIX. Regulation of86Rb+ efflux from perifused islets. Am. J. Physiol.236 (1979) E139-E146.
Brown, G.R., and Foubister, A.J., Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids. J. med. Chem.27 (1984) 79–81.
Couturier, E., and Malaisse, W.J., Insulinotropic effects of hypoglycaemic and hyperglycaemic sulphonamides: The ionophoretic hypothesis. Diabetologia19 (1980) 335–340.
Couturier, E., and Malaisse, W.J., Ionophoretic activity of hypoglycaemic sulfonylureas. Archs int. Pharmacodyn. Ther.245 (1980) 323–334.
Couturier, E., and Malaisse, W.J., Synergistic effects of hypoglycaemic sulphonylureas and antibiotic ionophores upon calcium translocation. Br. J. Pharmac.71 (1980) 315–320.
Curry, D.L., Is there a common beta cell insulin compartment stimulated by glucose and tolbutamide? Am. J. Physiol.220 (1971) 319–323.
Curry, D.L., Bennett, L.L., and Grodsky, G.M., Requirement for calcium ion in insulin secretion by the perfused rat pancreas. Am. J. Physiol.214 (1968) 174–178.
Danielsson, Å., Hellman, B., and Idahl, L.-Å., Levels of α-ketoglutarate and glutamate in stimulated pancreatic β-cells. Horm. Metab. Res.2 (1970) 28–31.
Dean, P.M., and Matthews, E.K., Electrical activity in pancreatic islet cells. Nature, Lond.219 (1968) 389–390.
Deleers, M., Couturier, E., Mahy, M., and Malaisse, W.J., Calcium transport in liposomes containing hypoglycemic and hyperglycemic sulfonamides. Archs int. Pharmacodyn. Ther.246 (1980) 170–172.
Deleers, M., Gelbcke, M., and Malaisse, W.J., Transport of Pr3+ by hypoglycemic sulfonylureas across liposomal membranes. FEBS Lett.151 (1983) 269–272.
Deleers, M., and Malaisse, W.J., Binding of hypoglycaemic sulphonylureas to an artificial phospholipid bilayer. Diabetologia26 (1984) 55–59.
Gabbay, K.H., and Tze, W.J., Inhibition of glucose-induced release of insulin by aldose reductase inhibitors. Proc. natl Acad. Sci. USA69 (1972) 1435–1439.
Grill, V., Role of cyclic AMP in insulin release evoked by glucose and other secretagogues. Horm. Metab. Res.,suppl. 10 (1980) 43–49.
Gylfe, E., Lysosomal activity and pancreatic β-cell function. Diabetologia7 (1971) 400.
Gylfe, E., Comparison of the effects of leucines, non-metabolizable leucine analogues and other insulin secretagogues on the activity of glutamate dehydrogenase. Acta diabetol. lat.13 (1976) 20–24.
Gylfe, E., Andersson, T., Rorsman, P., Abrahamsson, H., Arkhammar, P., Hellman, P., Hellman, B., Oie, H.K., and Gazdar, A.F., Depolarization independent net uptake of calcium into clonal insulin-releasing cells exposed to glucose. Biosci. Rep.3 (1983) 927–937.
Gylfe, E., and Hellman, B., Role of glucose as a regulator and precursor of amino acids in the pancreatic β-cell. Endocrinology94 (1974) 1150–1156.
Gylfe, E., and Hellman, B., Lack of Ca2+ ionophoretic activity of hypoglycemic sulfonylureas in excitable cells and isolated secretory granules. Molec. Pharmac.22 (1982) 715–720.
Gylfe, E., Hellman, B., Arvidson, G., and Sandblom, J., Effects of hypoglycemic sulfonylureas on Ca2+ fluxes across lipid bilayers. Biochem. Med.31 (1984) 246–253.
Hellman, B., Carbutamide stimulation of glutamic dehydrogenase activity in the pancreatic β-cells from obese-hyperglycemic mice. Metabolism16 (1967) 1059–1063.
Hellman, B., Factors affecting the uptake of glibenclamide in microdissected pancreatic islets rich in β-cells. Pharmacology11 (1974) 257–267.
Hellman, B., Potentiating effects of drugs on the binding of glibenclamide to pancreatic beta cells. Metabolism23 (1974) 839–846.
Hellman, B., Tolbutamide stimulation of45Ca fluxes in microdissected pancreatic islets rich in β-cells. Molec. Pharmac.20 (1981) 83–88.
Hellman, B., The mechanism of sulfonylurea stimulation of insulin release. Acta biol. med. germ.41 (1982) 1211–1219.
Hellman, B., Differences between the effect of tolbutamide and Ca2+ ionophores on efflux from pancreatic β-cells. Pharmac. Res. Commun.14 (1982) 701–710.
Hellman, B., Idahl, L.-Å., and Danielsson, Å., Adenosine triphosphate level of mammalian pancreatic β-cells after stimulation with glucose and hypoglycemic sulfonylureas. Diabetes18 (1969) 509–516.
Hellman, B., Idahl, L.-Å., Lernmark, Å., Sehlin, J., and Täljedal, I.-B., Membrane sulphydryl groups and the pancreatic beta cell recognition of insulin secretagogues. Excerpta Medica, Int. Congr. Ser.312 (1974) 65–78.
Hellman, B., Lenzen, S., Sehlin, J., and Täljedal, I.-B., Effects of various modifiers of insulin release on the lanthanum-nondisplaceable45Ca uptake by isolated pancreatic islets. Diabetologia13 (1977) 49–53.
Hellman, B., Lernmark, Å., Sehlin, J., Söderberg, M., and Täljedal, I.-B., On the possible role of thiol groups in the insulin-releasing action of mercurials, organic disulphides, alkylating agents and sulfonylureas. Endocrinology99 (1976) 1398–1406.
Hellman, B., Lernmark, A., Sehlin, J., and Täljedal, I.-B., The pancreatic β-cell recognition of insulin secretogogues. Inhibitory effects of a membrane probe on the islet uptake and insulin-releasing action of glibenclamide. FEBS Lett.34 (1973) 347–349.
Hellman, B., Sehlin, J., and Täljedal, I.-B., The pancreatic β-cell recognition of insulin secretagogues. II. Site of action of tolbutamide. Biochem. biophys. Res. Commun.45 (1971) 1384–1388.
Hellman, B., Sehlin, J., and Täljedal, I.-B., Effects of glucose and other modifiers of insulin release on the oxidative metabolism of amino acids in microdissected pancreatic islets. Biochem. J.123 (1971) 513–521.
Hellman, B., Sehlin, J., and Täljedal, I.-B., The pancreatic β-cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylureas. Diabetologia9 (1973) 210–216.
Hellman, B., Sehlin, J., and Täljedal, I.-B., Ionic effects on the uptake of sulfonylurea (glibenclamide) by pancreatic islets. Horm. Metab. Res.8 (1976) 427–429.
Hellman, B., Sehlin, J., and Täljedal, I.-B., Glibenclamide is exceptional among hypoglycemic sulfonylureas in accumulating progressively in β-cell-rich pancreatic islets. Acta endocr.105 (1984) 385–390.
Hellman, B., and Täljedal, I.-B., Effects of sulfonylurea derivatives on pancreatic β-cells, in: Insulin II. Handbook of Experimental Pharmacology, vol. 32, part 2, pp. 175–194. Eds A. Hasselblatt and F.v. Bruchhausen. Springer Verlag, Berlin 1975.
Henquin, J.C., D-glucose inhibits potassium efflux from pancreatic islet cells. Nature271 (1978) 271–273.
Henquin, J.C., Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets. Diabetologia18 (1980) 151–160.
Henquin, J.-C., and Meissner, H.P., Opposite effects of tolbutamide and diazoxide on86Rb+ fluxes and membrane potential in pancreatic β-cells. Biochem. Pharmac.31 (1982) 1407–1415.
Joost, H.G., and Holze, S., Uptake of tolbutamide by islets of Langerhans and other tissues. Experientia34 (1978) 1372–1373.
Judzewitsch, R.G., Pfeifer, M.A., Best, J.D., Beard, J.C., Halter, J.B., and Porte, D. Jr, Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose. J. clin. Endocr. Metab.55 (1982) 321–328.
Kaubisch, N., Hammer, R., Wollheim, C., Renold, A.E., and Offord, R.E., Specific receptors for sulfonylureas in brain and in a β-cell tumor of the rat. Biochem. Pharmac.31 (1982) 1171–1174.
Kawazu, S., Sener, A., Couturier, E., and Malaisse, W.J., Metabolic, cationic and secretory effects of hypoglycemic sulfonylureas in pancreatic islets. Naunyn Schmiedebergs Arch. Pharmak.312 (1980) 277–283.
Khatim, M.S., Gumaa, K.A., Hallberg, A., Eriksson, U., and Hellerström, C., Effect of a hypoglycaemic sulphonylurea (HB 419) and a non-metabolizable amino acid (BCH) on the insulin release and endogenous substrate metabolism of rat pancreatic islets. Acta endocr.103 (1983) 248–253.
Krzanowski, J.J., Fertel, R., and Matschinsky, F.M., Energy metabolism, in pancreatic islets of rats. Studies with tolbutamide and hypoxia. Diabetes20 (1971) 598–606.
Lebrun, P., Malaisse, W.J., and Herchuelz, A., Modalities of gliclazide-induced Ca2+ influx into the pancreatic β-cell. Diabetes31 (1982) 1010–1015.
Lundquist, I., Acid amyloglucosidase and carbohydrate regulation. III. The induction of sulphonylurea-stimulated insulin release and its dependence on intracellular monoamines. Horm. Metab. Res.4 (1972) 341–348.
Malaisse, W.J., Hubinont, C., Lebrun, P., Herchuelz, A., Couturier, E., Deleers, M., Malaisse-Lagae, F., and Sener, A., Mode of action of hypoglycaemic sulfonylureas in the pancreatic β-cell: coinciding and conflicting views, in: Clinical and Pharmacological Activities of Sulfonylurea Drugs, pp. 24–38. Eds M. Serrano-Rios and L.P. Krall. Excerpta Medica, Amsterdam 1983.
Malaisse, W.J., Mahy, M., Brisson, G.R., and Malaisse-Lagae, F., The stimulus-secretion coupling of glucose-induced insulin release. VIII. Combined effects of glucose and sulfonylureas. Eur. J. clin. Invest.2 (1972) 85–90.
Malaisse, W.J., Pipeleers, D.G., and Mahy, M., The stimulussecretion coupling of glucose-induced insulin release. XII. Effects of diazoxide and gliclazide upon45calcium efflux from perifused islets. Diabetologia9 (1973) 1–5.
Matthews, E.K., and Dean, P.M., The biophysical effects of insulin releasing agents on islet cells. Postgrad. med. J.46, suppl. 1 (1970) 21–23.
Meissner, H.P., and Atwater, I.J., The kinetics of electrical activity of beta cells in response to a ‘square wave’ stimulation with glucose or glibenclamide. Horm. Metab. Res.8 (1976) 11–16.
Meissner, H.P., Preissler, M., and Henquin, J.C., Possible ionic mechanisms of the electrical activity induced by glucose and tolbutamide in pancreatic β-cells. Excerpta Medica Int. Congr. Ser.500 (1979) 166–171.
Norlund, L., and Sehlin, J., Effect of glibenclamide on the osmotic resistance of pancreatic β-cells. Acta physiol. scand.120 (1984) 407–415.
Panten, U., Biochemical events in pancreatic islets as caused by sulfonylurea derivatives, in: Pharmacology and the Future of Man. Proc. 5th Int. Congr. Pharmac. San Francisco 1972, vol. 3, pp. 214–220. Eds. G.T. Okita and G.H. Acheson. Karger, Basel 1973.
Pfeifer, M.A., Halter, J.B., and Porte, D., Jr, Insulin secretion in diabetes mellitus. Am. J. Med.70 (1981) 579–588.
Pressman, B.C., Properties of ionophores with broad range cation selectivity. Fedn Proc.32 (1973) 1698–1703.
Schmidt, S., Wilke, B., Ziegler, B., Jahr, H., and Zühlke, H., Changes in glucose-stimulated insulin secretion after long-term treatment of C57Bl mice with glibenclamide. Endokrinologie76 (1980) 167–170.
Sehlin, J., Evidence for specific binding of tolbutamide to the plasma membrane of the pancreatic β-cells. Acta diabetol. lat.10 (1973) 1052–1060.
Sehlin, J., Are Cl− mechanisms in mouse pancreatic islets involved in insulin release? Ups. J. med. Sci.86 (1981) 177–182.
Sehlin, J., and Täljedal, I.-B., Transport of rubidium and sodium in pancreatic islets. J. Physiol., Lond.242 (1974) 505–515.
Sehlin, J., and Täljedal, I.-B., Glucose-induced decrease in Rb+ permeability in pancreatic β-cells. Nature253 (1975) 635–636.
Sener, A., and Malaisse, W.J., L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature288 (1980) 187–189.
Stork, H., Schmidt, F.H., Westman, S., and Hellerström, C., Action of some hypoglycaemic sulphonylureas on the oxygen consumption of isolated pancreatic islets of mice. Diabetologia5 (1969) 279–283.
Täljedal, I.-B., Uptake of glibenclamide by microdissected pancreatic islets. Horm. Res.5 (1974) 211–216.
Täljedal, I.-B., On insulin secretion. Diabetologia21 (1981) 1–17.
Täljedal, I.-B., Insulin secretion mechanisms and experimental models of diabetes, in: Recent Trends in Diabetes Research. Skandia Int. Symp., pp. 145–174. Eds H. Boström and N. Ljungstedt. Almqvist & Wiksell International, Stockholm 1982.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gylfe, E., Hellman, B., Sehlin, J. et al. Interaction of sulfonylurea with the pancreatic B-cell. Experientia 40, 1126–1134 (1984). https://doi.org/10.1007/BF01971460
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01971460